关注
Shengsheng Xu
Shengsheng Xu
Frontage laboratories Inc
在 frontagelab.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mechanism of reduction in IgG and IgE binding of β-lactoglobulin induced by ultrasound pretreatment combined with dry-state glycation: A study using conventional spectrometry …
W Yang, Z Tu, H Wang, L Zhang, S Xu, C Niu, H Yao, IA Kaltashov
Journal of agricultural and food chemistry 65 (36), 8018-8027, 2017
712017
Morphology transformation via pH-triggered self-assembly of peptides
SY Qin, SS Xu, RX Zhuo, XZ Zhang
Langmuir 28 (4), 2083-2090, 2012
472012
Controllable micro/nanostructures via hierarchical self-assembly of cyclopeptides
SY Qin, YF Chu, L Tao, SS Xu, ZY Li, RX Zhuo, XZ Zhang
Soft Matter 7 (18), 8635-8641, 2011
302011
Simultaneous quantification of total antibody and antibody-conjugated drug for XMT-1522 in human plasma using immunocapture-liquid chromatography/mass spectrometry
L Xu, Z Zhang, S Xu, J Xu, ZJ Lin, DH Lee
Journal of Pharmaceutical and Biomedical Analysis 174, 441-449, 2019
122019
Evaluation of Gallium as a Tracer of Exogenous Hemoglobin–Haptoglobin Complexes for Targeted Drug Delivery Applications
S Xu, IA Kaltashov
Journal of The American Society for Mass Spectrometry 27 (12), 2025-2032, 2016
102016
Application of middle-down approach in quantitation and catabolite identification of protein by LC–high-resolution mass spectrometry
L Kang, S Xu, Y Pang, T Kirchner, Y Zhang, W Edwards, R Camacho, ...
Bioanalysis 13 (6), 465-479, 2021
12021
Overcoming the Hydrolytic Lability of a Reaction Intermediate in Production of Protein/Drug Conjugates: Conjugation of an Acyclic Nucleoside Phosphonate to a Model Carrier Protein
S Xu, IA Kaltashov
Molecular Pharmaceutics 14 (8), 2843-2851, 2017
12017
系统目前无法执行此操作,请稍后再试。
文章 1–7